Research and Development Division
Development of Novel Cancer Therapies
As a technology-driven company specializing in virus engineering, vectors, and the development of novel cancer therapies, we conduct extensive and targeted research and development activities, supported by a team of experts and state-of-the-art laboratory infrastructure. Adherence to international GLP standards in research and GMP conditions in production enables us to manage and execute biological and bioinformatics projects from the design stage through to the final product.
Capabilities and Services
- Design and construction of innovative vectors
- Conducting cellular assays and preclinical animal studies
- Production of biological products under GMP conditions
- Documentation and preparation of CTD dossiers approved by regulatory authorities
Research Areas
- Advanced Immunotherapies: Including CAR-T cell therapy and oncolytic viruses with global regulatory approval. These projects are currently being localized and produced under GMP conditions.
- Engineering and Production of Oncolytic Viruses: Design, replication, and purification of viruses at high titers and advanced purity to achieve maximal efficacy in clinical trials.
- Vector and Virus Bank: Establishment and expansion of a comprehensive repository of vectors and oncolytic viruses to support research and the development of future therapies.
- Cell Bank: Preparation and storage of a diverse collection of cell lines, particularly cancer cells and virus-host cells.
- Cellular Immunotherapy Research: Including the engineering and design of specialized vectors to enhance the efficacy of CAR-T-based therapies.
Vision
Our vision is to develop innovative and accessible therapies for patients. By combining scientific knowledge, advanced technology, and collaboration with universities and research centers, we aim to localize immunotherapy technologies and enhance national capabilities in cancer treatment.
Have an innovative idea?
We reach out to researchers and innovators in knowledge-based companies, fostering collaboration and driving the future of science together.